Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Recurrent or Persistent Endometrial Carcinoma
NCT00023894Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jul 2001
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 2, open-label, single-arm trial of alvocidib in endometrial carcinoma, sponsored by GOG Foundation. Primary endpoints: Objective Response Rate and Adverse Events. Started Jul 2001; status: completed.
02
Drugs
alvocidib
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00023894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023894.